Metergoline
Metergoline is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2C, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 1F, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 1B, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 1D, and 5-hydroxytryptamine receptor 7.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | METERGOLINE |
INN | metergoline |
Description | Metergoline is an ergoline alkaloid that is the N-benzyloxycarbonyl derivative of lysergamine. A 5-HT2 antagonist. Also 5-HT1 antagonist and 5-HT1D ligand. Has moderate affinity for 5-HT6 and high affinity for 5-HT7. It has a role as a serotonergic antagonist, a dopamine agonist and a geroprotector. It is an ergoline alkaloid and a carbamate ester. |
Classification | Small molecule |
Drug class | ergot alkaloid deriviatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21 |
Identifiers
PDB | — |
CAS-ID | 17692-51-2 |
RxCUI | 6834 |
ChEMBL ID | CHEMBL19215 |
ChEBI ID | 64216 |
PubChem CID | 28693 |
DrugBank | DB13520 |
UNII ID | 1501393LY5 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
HTR6
HTR6
HTR2C
HTR2C
HTR5A
HTR5A
HTR2B
HTR2B
HTR1F
HTR1F
HTR2A
HTR2A
HTR1B
HTR1B
HTR1E
HTR1E
HTR1D
HTR1D
HTR7
HTR7
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 471 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
9 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more